Shots:
- ONWARD Medical has enrolled the first patient in its Empower BP study evaluating ARC-IM System for symptomatic blood pressure instability in patients with chronic spinal cord injury
- The global trial will assess ARC-IM System against a sham in pts with C2–T6 spinal cord injuries & injury severities of AIS A-D across ~20 centers in the US, Canada, & EU
- The System showed rapid, durable blood pressure increase as published in Nature Medicine (Sept 2025), with multi-year studies showing sustained symptom relief, QoL gains, reduced fatigue & benefits lasting up to 2yrs. post-implantation
Ref: Globenewswire | Image: ONWARD Medical | Press Release
Related News: ONWARD Medical’s ARC-EX System Receives the European CE Mark Approval for Spinal Cord Stimulation
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
